India, Feb. 24 -- In its effort to bring innovations from the lab to the real world,National Institute of Technology Rourkela (NIT Rourkela)spined out Startup Miraqules MedSolutions has received regulatory approval for commercial manufacturing and clinical deployment of its patented technology, a rapid nano-biopolymer hemostat, to transform emergency hemorrhage control.

StopBleed(R), the technology developed at NIT Rourkela, has received approval from the Central Drugs Standard Control Organisation (CDSCO) as a Class C medical device, marking a significant step in translating academic research into real-life-saving medical technology.

The product facilitates for rapid control of severe bleeding arising from road accidents, gunshot wound...